| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $302K | -3.8% |
| R&D Expense | $238.3M | +49.1% |
| SG&A Expense | $61.1M | -35.7% |
| Operating Income | -$299.0M | -17.5% |
| Net Income | -$269.9M | -13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $738.5M | +51.8% |
| Total Assets | $742.4M | +51.4% |
| Current Liabilities | $47.9M | +79.7% |
| Long-term Debt | $20.6M | +1.9% |
| Total Liabilities | $70.8M | +46.2% |
| Stockholders' Equity | $671.6M | +51.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$232.3M | -26.1% |
| Capital Expenditures | $511K | -43.1% |
| Investing Cash Flow | -$228.7M | -142.6% |
| Financing Cash Flow | $457.7M | +102.8% |
| Free Cash Flow | -$232.8M | -25.8% |